11 / 12
July 2015
| Business World
121
the patient,” Conley said. “There is a pain scale
from 0-10 on the front of the device, and they
touch the button that relates to their pain lev-
el and it turns on the radio frequency identi-
fication reader in the device to recognize the
patient bracelet and if that device recognizes
the bracelet, it will dispense a dose of medica-
tion.”
“The ability of the modern software to ob-
tain the patient pain database and express it
numerically and graphically, is another great
feature,” she continued. “The fact that we pro-
vide the software to display this for the treat-
ment team and take the data and send it to the
electronic medical record is unique because
there are no other devices for pain manage-
ment in today’s hospitals that reflect this kind
of database.”
THE FUTURE
A collective purpose and shared vision is
Avancen’s greatest asset. Looking to not only
build a profitable venture but also improve
patient care at the bedside, the unrivaled ex-
perience and expertise afforded by the device
and the human capital responsibility for mak-
ing it a reality, continues to define their move-
ment going forward.
“There is a significant need for this technol-
ogy in all healthcare facilities around the
world that practice state of the art acute care
and medicine,” Conley said. “Our goal is to
expand into the EU and Canada. This tech-
nology will be used in the global healthcare
market, not just the United States. Patient-
centered care and the ability to involve pa-
tients is a focus that spans the globe.”
As the global shortage of nurses continues to
rise, looking for ways to improve efficiency is
crucial. With capabilities to put the patient
in control and save nursing time, Avancen
and the MOD are leading the way in an in-
novative and groundbreaking way. With a
big push towards continuity of care between
hospitals and rehab facilities, and the ongoing
development of the company’s new ambula-
tory device, demand from all angles is a defi-
nite certainty.
“There are many ways we plan to expand our
market from acute care into global hospital
markets and beyond,” Conley said. “We have
a lot left to do.”